DermaPure® is one of the two innovative tissue products (along with VNEW®) that ARMS Medical is proud to offer patients, using patented dCELL® Technology
DermaPure® is a decellularized dermal tissue with virtually no structural disruption allowing tissue and cellular regeneration to occur. DermaPure® has been demonstrated to provide higher pro-angiogenic response during integration with reduced fibrosis.1
DermaPure® is available in four sizes:
Facilitates the re-establishment of vascular channels, enabling successful graft take in just seven days.
Treatment with DermaPure® had the strongest pro-angiogenic influence, particularly within 3 – 4 weeks.
Treatment with DermaPure® resulted in reduced fibrosis compared to the control and xenograft.
Suitable for abdominal, trans-vaginal and robotic surgery.
Optimizes graft handling and high suture pullout strength while retaining strong biomechanical properties.
Designed for pelvic floor conditions and gender affirmation surgeries, VNEW adapts to various surgical approaches, enhancing patient care.
These procedures help to treat concerns such as:
References
Copyright © 2024 ARMS
Medical. All Rights Reserved.